Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron Snell

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Human Pathology|June 24, 2022
Isotypic analysis of anti-p53 serum autoantibodies and p53 protein tissue phenotypes in colorectal cancerMr Md Saiful Islam Roney, Ms Catharine Lanagan, Yonghua Sheng, et al.
Cancer Research|May 20, 2016
Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor GrowthAlan McIntyre, Alzbeta Hulikova, Ioanna Ledaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Blood|December 20, 2019
EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2Alexandre S Cristino, Jamie Nourse, Rachael A West, et al.
Molecular Cancer Research : MCR|August 5, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune SuppressionHelen Sheldon, Esther Bridges, Ildefonso Silva, et al.
The American Journal of Surgical Pathology|April 4, 2025
Molecular Analysis of Cutaneous Sarcomatoid Neoplasms Frequently Identifies Melanoma Driver VariantsLouise A Jackett, Catherine Mitchell, Cameron Snell, et al.
Cancers|August 7, 2021
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour RegressionMartina Proctor, Jazmina L Gonzalez Cruz, Sheena M Daignault-Mill, et al.
Molecular Oncology|May 3, 2019
Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabineZay Yar Oo, Martina Proctor, Alexander J Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2006
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelinationBen Emery, Holly S Cate, Mark Marriott, et al.
Cell Metabolism|November 27, 2012
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cellsElena Favaro, Karim Bensaad, Mei G Chong, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Human Pathology|June 24, 2022
Isotypic analysis of anti-p53 serum autoantibodies and p53 protein tissue phenotypes in colorectal cancerMr Md Saiful Islam Roney, Ms Catharine Lanagan, Yonghua Sheng, et al.
Cancer Research|May 20, 2016
Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor GrowthAlan McIntyre, Alzbeta Hulikova, Ioanna Ledaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Blood|December 20, 2019
EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2Alexandre S Cristino, Jamie Nourse, Rachael A West, et al.
Molecular Cancer Research : MCR|August 5, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune SuppressionHelen Sheldon, Esther Bridges, Ildefonso Silva, et al.
The American Journal of Surgical Pathology|April 4, 2025
Molecular Analysis of Cutaneous Sarcomatoid Neoplasms Frequently Identifies Melanoma Driver VariantsLouise A Jackett, Catherine Mitchell, Cameron Snell, et al.
Cancers|August 7, 2021
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour RegressionMartina Proctor, Jazmina L Gonzalez Cruz, Sheena M Daignault-Mill, et al.
Molecular Oncology|May 3, 2019
Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabineZay Yar Oo, Martina Proctor, Alexander J Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2006
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelinationBen Emery, Holly S Cate, Mark Marriott, et al.
Cell Metabolism|November 27, 2012
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cellsElena Favaro, Karim Bensaad, Mei G Chong, et al.
Pageof 3